Baumgartner, Joel M.
Raymond, Victoria M.
Lanman, Richard B.
Tran, Lisa
Kelly, Kaitlyn J.
Lowy, Andrew M.
Kurzrock, Razelle
Article History
Received: 20 March 2018
First Online: 14 June 2018
Disclosures
: Dr. Kurzrock has received research funding from Incyte, Genentech, Merck Serono, Pfizer, Sequenom, Foundation Medicine, and Guardant Health; consultant fees from Sequenom, Loxo and Actuate Therapeutics; and speaker fees from Roche. He also has an ownership interest in Curematch, Inc. Ms. Raymond and Dr. Lanman are employees at Guardant Health, Inc. Drs. Baumgartner, Kelly, Lowy and Ms. Tran have no relevant disclosures.